Glenmark Pharmaceuticals Ltd.(GLENMARK) · NSE
Sector: CNXPHARMA | Last updated: 14 Oct 2026
Glenmark Pharmaceuticals Ltd. (GLENMARK) is showing Bearish momentum today, with an Altra Score of 30.8 on AltraOne's multi-timeframe (MTF) momentum analysis. The stock is part of the CNXPHARMA sector, where it ranks 15 by relative strength in a currently bearish RS regime (Relative Strength: 8.83). Recent EMA crossover activity: Close below 30W EMA. GLENMARK closed at 2250.50 on 14 Oct 2026 (+0.38% for the day), based on end-of-day (EOD) price data rather than a live quote.
Price
Stock Relative Strength
Latest EMA CrossOvers
GLENMARK's Daily RSI(14) is 41.1 (up 0.5 from prior), Weekly RSI is 48.1 (down 2.9 from prior), and Monthly RSI is 62.0 (down 4.5 from prior). Price is currently trading above its Daily EMA 200, but below its Daily EMA 8, Daily EMA 20, Daily EMA 50, Weekly EMA 8, Weekly EMA 30.
Multi-Timeframe RSI (14)
| Timeframe | RSI | Prev | Change |
|---|---|---|---|
| Daily | 41.1 | 40.6 | ▲ 0.5 |
| Weekly | 48.1 | 51.0 | ▼ 2.9 |
| Monthly | 62.0 | 66.5 | ▼ 4.5 |
Stock Price and EMA Placement
History
TradingView ↗The current active signal for GLENMARK is Bullish, triggered on 06 Jun 2025 at a price of 1590.20. Since then, the stock has gained 41.52%.
These are long-term momentum shifts, not buy/sell recommendations.
Price Chart — GLENMARK
Open on TradingViewLive chart not available for NSE stocks in the free embed. View GLENMARK on TradingView ↗